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Abstract
Background: Aedes aegypti and Ae. albopictus are the main epidemic vectors of dengue, chikungunya and Zika
viruses worldwide. Their control during epidemics relies mainly on control of larvae and adults with insecticides.
Unfortunately, loss of susceptibility of both species to several insecticide classes limits the efficacy of interventions.
In Africa, where Aedes-borne viruses are of growing concern, few data are available on resistance to insecticides. To
fill this gap, we assessed the susceptibility to insecticides of Ae. aegypti and Ae. albopictus populations in the Central
African Republic (CAR) and studied the mechanisms of resistance.
Methods: Immature stages were sampled between June and September 2014 in six locations in Bangui (the capital
of CAR) for larval and adult bioassays according to WHO standard procedures. We also characterized DDT- and
pyrethroid-resistant mosquitoes molecularly and biochemically, including tests for the activities of nonspecific
esterases (α and β), mixed-function oxidases, insensitive acetylcholinesterase and glutathione S-transferases.
Results: Larval bioassays, carried out to determine the lethal concentrations (LC50 and LC95) and resistance ratios
(RR50 and RR95), suggested that both vector species were susceptible to Bacillus thuringiensis var. israeliensis and to
temephos. Bioassays of adults showed susceptibility to propoxur and fenitrothion, except for one Ae. albopictus
population that was suspected to be resistant to fenithrothion. None of the Ae. aegypti populations was fully
susceptible to DDT. Ae. albopictus presented a similar profile to Ae. aegypti but with a lower mortality rate (41%).
Possible resistance to deltamethrin was observed among Ae. aegypti and Ae. albopictus, although some were
susceptible. No kdr mutations were detected in either species; however, the activity of detoxifying enzymes was
higher in most populations than in the susceptible Ae. aegypti strain, confirming decreased susceptibility to DDT
and deltamethrin.
Conclusion: These findings suggested that regular, continuous monitoring of resistance is necessary in order to
select the most effective adulticides for arbovirus control in Bangui.
Keywords: Aedes aegypti, Aedes albopictus, Arboviruses, Vectors, Insecticide resistance, Metabolic resistance, Central
African Republic
* Correspondence: ngoagounic@yahoo.fr
1Institut Pasteur de Bangui, PO Box 923, Bangui, Central African Republic
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ngoagouni et al. Parasites & Vectors  (2016) 9:599 
DOI 10.1186/s13071-016-1887-5
Background
Aedes aegypti and Ae. albopictus are the main vectors of
dengue virus (DENV, Flaviviridae, Flavivirus), chikungunya
virus (CHIKV, Togaviridae, Alphavirus) and Zika virus
(ZIKV, Flaviviridae, Flavivirus) worldwide. Aedes aegypti is
native to Africa and is found throughout the tropics,
whereas Ae. albopictus is native to Asia but has recently
spread to all continents. These three viruses are increasing
global health threats, spreading from their original niches
to most areas of the world. Dengue virus infection is a
serious health problem for 2.5 billion people worldwide.
A recent estimate indicated 390 million infections per
year (95% credible interval, 284–528 million), of which
96 million (67–136 million) manifest clinically, although
the actual number of cases is under-reported, and many
cases are not definitively classified [1]. Dengue infection
causes more illness and deaths in humans than any other
arboviral disease, the severity ranging from mild dengue
fever to dengue haemorrhagic fever and dengue shock
syndrome. Chikungunya fever is also as a significant
worldwide public health problem; particular attention has
been paid to this disease after its rapid, massive emergence
in the south-west Indian Ocean, India and the Americas
[2]. Chikungunya can manifest as asymptomatic to severe
infections, mainly with severe arthralgia but also with car-
diovascular, neurological and respiratory symptoms [3, 4].
ZIKV, which was originally isolated in 1947 from a
monkey in Uganda [5], has occasionally been reported in
humans in Africa and Asia [6], but, after its sudden emer-
gence in 2007 on Yap Island, affecting about 5,000 people
[7], it caused successive outbreaks in French Polynesia in
2013–2014 [8] and in Brazil since October 2015, before
spreading across Latin America [9]. The recrudescence of
ZIKV has been associated with reports of neurological
disorders and microcephaly, and the World Health
Organization (WHO) declared it a “public health emer-
gency of international concern” on 1 February 2016 [10].
In Central Africa, several arboviruses, including DENV,
CHIKV and ZIKV have been isolated from mosquitoes
and human samples, but no massive outbreak was re-
ported before introduction of the new competent vector
Ae. albopictus. After it was first reported in 2000 in
Cameroon [11], it spread rapidly to numerous countries
in Central Africa and, with the native species Ae. aegypti,
played a role in disseminating and spreading DENV,
CHIKV and ZIKV in urban and rural environments
[6, 12–14]. This change in the epidemiology of these
three arboviruses is particularly disturbing because the re-
gion has many potentially suitable niches for Ae. albopic-
tus, and several arboviruses of medical and veterinary
concern are endemic [15]. In view of the current lack of
effective vaccines or specific drugs against these arboviral
infections, vector control remains the most effective
means for their prevention [16].
Insecticides play a major role in the control of mos-
quito vectors, and synthetic pyrethroids are the chemi-
cals of choice because of their effective, rapid activity
against insects, their low toxicity for mammals and their
degradability in the environment [17, 18]. WHO recom-
mends use of pyrethroids against adult mosquitoes and
larvicides such as Bacillus thuringiensis var. israeliensis
(Bti), organophosphates like temephos, benzoylureas like
diflubenzuron, juvenile hormone mimics like pyriproxy-
fen and spinosyns such as spinosad for larval control
[19]. Unfortunately, long-term intensive use of insecti-
cides usually leads to the emergence of resistance in
mosquito species under selection pressure, and this is
one of the major obstacles to the control of arthropod
pests [20, 21]. Many control programmes are threatened
by insecticide resistance in Ae. aegypti and Ae. albopictus.
Aedes aegypti has been reported to be resistant to pyre-
throids and organophosphates in various part of the world,
whereas few data are available on insecticide resistance in
Ae. albopictus. The few studies that have been conducted
show decreased susceptibility of Ae. albopictus to a wide
variety of active ingredients, including organophosphates,
organochlorines (DDT) and pyrethroids.
Insecticide resistance in insects is due to two main
mechanisms: enhanced metabolic detoxification and in-
sensitivity of target sites [22]. The first mechanism involves
overexpression or qualitative changes in the catalytic sites
of enzymes such as non-specific esterases (NES), glutathi-
one S-transferases (GST) and mixed-function oxidases
(MFO). Previous studies outside Africa on metabolic resist-
ance mechanism in Ae. aegypti and Ae. albopictus showed
that most of detoxification enzymes linked to insecticide
resistance belong to the cytochrome P450 genes [23, 24].
Target insensitivity is due to mutations that reduce the
binding affinity between the insecticide and its physio-
logical target. Pyrethroids and DDT acts on voltage-sen-
sitive sodium channels, and insects develop resistance to
these types of insecticide through substitution(s) of one or
several amino acids in the channel sequence [25]. These
mutations in the voltage-sensitive sodium channel are
known as “knockdown resistance” (kdr) and have been re-
ported in several mosquito genera, including Anopheles
gambiae [26], An. stephensi [27], Culex pipiens [28] and
Ae. aegypti [29]. In many mosquito species, including Ae.
aegypti, kdr related to pyrethroids and DDT has been lo-
cated in segment 6 of domain II [23, 29–31], with other
mutations at the same position (I1011M, I1011V,V1016G
and V1016I) [32]. In South-East Asia, for example, two
major voltage-gated sodium channel haplotypes (S989P +
V1016G and F1534C) confer resistance of Ae. aegypti
to pyrethroids, and species with these two haplotypes
are widely and sympatrically distributed in that region
[33–35]. Neurophysiological studies have revealed that
V1016G and F1534C single mutations each confer
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resistance to pyrethroids [36]. Such kdr mutations are
rare in Ae. albopictus; the mutation F1534C (TTC to
TGC) at segment 6 of domain III described in Ae.
aegypti is the only one that has been confirmed in Ae.
albopictus from Singapore [37].
In Africa, most of the data on insecticide susceptibility
concerns malaria vectors (Anopheles mosquitoes), and
very little is known about Aedes. Most of the studies on
Ae. aegypti in West and Central Africa date back 30–40
years [38], although resistance of Ae. aegypti and Ae.
albopictus was reported in Cameroon after introduction
of Ae. albopictus [39]. In CAR, both species are present,
but Ae. albopictus predominates over Ae. aegypti at all
sites in Bangui and southern CAR, where the two spe-
cies are sympatric [40]. The lack of data on their suscep-
tibility to insecticides used in public health is a growing
obstacle for dengue, chikungunya and Zika disease con-
trol programmes. We assessed the susceptibility of lar-
vae and adults of Ae. aegypti and Ae. albopictus to
insecticides and the mechanism involved in order to se-
lect the best insecticides for use in an outbreak and to
manage resistance in these populations.
Methods
Mosquito strains and collection
Field-caught larval or pupal Ae. aegypti and Ae. albopic-
tus (F0 generation) were sampled between June and
September 2014, during the rainy season, in six districts
of Bangui (Fig. 1). All samples were taken to the insect-
aries at the Institut Pasteur de Bangui (IPB) and main-
tained under controlled conditions (28 ± 2 °C and 80 ±
10% relative humidity); larvae were fed dry cat food.
After emergence, adult Aedes mosquitoes were identi-
fied morphologically [41], grouped by species and site
into cages and fed 10% sugar solution. Some of the F0
adults were used in adult bioassays, molecular and bio-
chemical studies, and the remainder were used to ob-
tain the next generation (F1). Females were allowed to
feed on blood from rabbits to induce egg-laying. F1 eggs
were hatched to obtain larvae for use in larval bioas-
says. The insecticides tested were chosen from the four
main classes of adulticides (organochlorines, pyrethroids,
carbamates and organophosphates) and two of larvicides
(Bti and temephos). The reference strain (Ae. aegypti SBE)
originating from Benin and papers impregnated with adul-
ticides and Bti were supplied by the MiVEGEC project
(Maladies Infectieuses et Vecteurs: Écologie, Génétique,
Évolution, contrôle) (Université de Montpellier, France).
Larval bioassays
Larval bioassays were performed according to standard
WHO guidelines [42] using F1 larvae. The susceptibility
of larvae was evaluated against technical-grade temephos
(97.3%; Sigma Aldrich-Pestanal®, Seelze, Germany) and a
Fig. 1 Map of Bangui showing sampling sites
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formulated Bti product (Vectobac® 12AS, 1200 ITU/mg).
First, stock solutions and serial dilutions were prepared
in 95% ethanol (temephos) or distilled water (Bti) and
stored at 4 °C. For Bti, five concentrations ranging from
0.08 to 0.2 mg/l and for temephos, eight doses ranging
from 0.0025 to 0.009 mg/l have been used in larval bio-
assay. Fifty to 100 larvae per concentration (with three
to four replicates, depending on the sample and the
number of larvae available) were tested. Third late or
early fourth-instar larvae of each species were placed in
plastic cups containing 99 ml of tap water, and 1 ml of
insecticide solution at the required concentration was
added. Control groups were run systematically with lar-
vae exposed to 1 ml of ethanol (for temephos) or 1 ml of
tap water (for Bti). No food was provided to larvae dur-
ing the bioassays, which were run at 28 ± 2 °C and 80 ±
10% relative humidity. Mortality was determined after
24 h of exposure to the insecticide. Mortality rates were
corrected with Abbott’s formula [43] when the mortality
of controls was > 5%.
All data were analysed with Win DL v. 2.0 software
[44]. Lethal concentrations (LC50 and LC95) were calcu-
lated with their 95% confidence intervals (CIs). Resist-
ance ratios (RR50 and RR95) were calculated by
comparing the LC50 and LC95 for each species with
those of susceptible strain, as RR50(95) = LC50(95) of stud-
ied population/LC50(95) susceptible strain and RR95 =
LC95(95) of studied population/LC95(95) reference strain.
Mosquito populations were considered as resistant when
RR was higher than 1 and confidence intervals for LC50
or LC95 did not overlap those of the susceptible refer-
ence strain.
Adult bioassays
Adult bioassays were performed with non-blood-fed fe-
males according to the standard WHO guidelines [42].
Four insecticides 4% DDT (organochlorine), 0.05% delta-
methrin (pyrethroid), 0.1% propoxur (carbamate) and
0.5% fenitrothion (organophosphate) were tested. Two
to four batches of 25 non-blood-fed females (2–4 days
of age) were introduced into WHO tubes containing im-
pregnated filter papers and exposed for 60 min. For
every test, a control assay was run in parallel with un-
treated papers. The number of knockdown (Kd) mosqui-
toes was counted every 5 min during the 60 min. After
exposure, females were transferred for 24 h into holding
tubes (and allowed to feed on a 10% sugar solution) be-
fore being checked for mortality. Assays were carried
out at 28 ± 2 °C and a relative humidity of 80 ± 10%. The
susceptibility of the mosquitoes was classified according
to the WHO criteria [45] as susceptible when mortality
was > 97%, resistant when mortality was < 90% and pos-
sibly resistant when mortality was 90–97%. Surviving fe-
males were killed and stored individually at -80 °C in
Eppendorf tubes (according to insecticide); dead mos-
quitoes were stored in silica gel. As in the larval bioas-
says, Win DL software version 2.0 was used to estimate
the KdT50 and KdT95 and their 95% CIs.
Screening of kdr mutation in Aedes aegypti and Aedes
albopictus
DDT- and deltamethrin-resistant specimens of Ae.
aegypti and Ae. albopictus were examined for the pres-
ence of kdr mutations. The total DNA of each surviving
specimen was extracted with the 2% cetyl trimethyl am-
monium bromide protocol described by Morlais et al.
[46], then resuspended in 1:50 μl sterile water and stored
at −20 °C. The sodium channel gene was examined by
PCR and direct sequencing of fragment encoding to ver-
ify the presence of mutations at I1011M or I1011V,
V1016G or V1016I and F1534C in Ae. aegypti and
F1534C in Ae. albopictus. In Ae. aegypti, we amplified
and sequenced a part of segment 6 of domain II with
the primers AaSCF1 and AaSCR4 [35] and domain III
with AaSCF7 and AaSCR7 [35]. Whereas, Ae. albopictus
was amplified with AaSCF7 and AaSCR7 [37] for do-
main III.
The PCR mixture contained 2.5 μl 10× buffer (Eurogen-
tec, USA), 1.5 MgCl2, 1 mM dNTP (Eurogentec, USA),
1 μl of 1/10 of each primer, 0.1 μl of Diamond Taq DNA
polymerase (Eurogentec, USA) and 4 μl of 1/50 diluted
total DNA in a total volume of 25 μl. DNA was amplified
in a GeneAmp 9600 thermal cycler (PerkinElmer, USA)
under the following conditions: 94 °C for 3 min, followed
by 40 cycles of 30 s at 94 °C, 45 s at the annealing
temperature 64 °C, 45 s at 72 °C and 10 min at 72 °C. PCR
products (10 μl) were migrated on 1.5% agarose gel in
TAE buffer, purified with AMPure® Agencourt® (Beckman
Coulter, Danvers MA, USA) when they contained ampli-
fied fragments of the expected size and then sequenced
with a BigDye Terminator v3.1 Cycle sequencing kit (Ap-
plied Biosystems, USA). The primers used for sequencing
were: AeSCF3 for I1011M/V, AeSCR6 for V1016G/I and
AeSCR8 for F1534C mutations in Ae. aegypti and AeSCR8
and AeSCR7 for the F1534C mutation in Ae. albopictus.
The sequence reaction was carried out in 9 μl of reac-
tion volume containing 1 μl of 5× buffer sequence, 1 μl
of primer (5 pmol), 1 μl of Big Dye terminator V3.1 and
1 μl of purified amplicons. Amplification was performed
at 96 °C for 1 min, followed by 25 cycles at 96 °C for
10 s, 50 °C for 5 s and 60 °C for 4 min. Direct DNA se-
quencing was performed on an automatic sequencer
ABI 3130XL (Applied BioSystems). Sequences were ana-
lysed with BioEdit version 7.2.5 [47].
Biochemical assays
In order to detect metabolic resistance, biochemical
analyses were performed on 2-3-day-old F0 mosquito
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females by the modified microplate methods described
by Hemingway & Karunaratne [48] and Brogdon et al.
[49]. None of the mosquitoes used had been exposed to
insecticide. For each experiment, at least 25 mosquitoes
per species were assayed for MFO, GST, acetylcholin-
esterase (AChE), α- and β-esterases and total proteins.
The SBE strain was used as the susceptible reference.
Two wells filled with 10 μl of sterile distilled water were
used as background (in two adjacent wells) for each
analysis. Mosquitoes were ground individually on ice in
200 μl of sterile distilled water. Before centrifugation,
25 μl of each homogenate were distributed in two adja-
cent wells of a microplate to test for acetylcholinester-
ase, and the rest of the homogenate was centrifuged at
14,000 rpm for 2 min. Total protein and other enzyme
systems were analysed in two replicates. The volume of
supernatant was 20 μl for MFO and 10 μl for GST, α-
and β-esterases and total proteins. Absorbance was mea-
sured in a spectrophotometer for microplate readers
(TECAN, Sunrise™) with Magellan version 7.0. software.
The ratios of the specific activities of enzymes to the
protein content of individual homogenates were deter-
mined in the Bradford assay [50]. Thus, 10 μl of each
homogenate was mixed in a microtitre plate well with
140 μl of Bradford reagent (Sigma-Aldrich, St Louis, USA),
and the mixture was incubated at room temperature for
5 min. The end-point absorbance was read at 595 nm.
Protein values were calculated from a standard curve of
absorbance of bovine serum albumin.
Mixed function oxidase assay
The assay used to measure mixed-function oxidases
detects increases in the amount of haem, which are
then converted into equivalent units of cytochrome
P450. Cytochrome P450 was titrated in the haem-
peroxidase assay according to Brogdon et al. [49]. Briefly,
80 μl of 0.625 M potassium phosphate buffer (pH 7.2)
were added to 20 μl of microfuged supernatant and
200 μl of tetramethylbenzidine solution (0.011 g 3,3′,5,5′-
tetramethylbenzidine + 5 ml methanol + 15 ml sodium
acetate buffer 0.25 M, pH 5.0). After addition of 25 μl
of 3% hydrogen peroxide, the mixture was incubated
for 15 min at room temperature with a cover. Absorb-
ance was read at 630 nm and values calculated from a
standard curve.
Glutathione S-transferase assay
Glutathione S-transferase was measured with a 200 μl 1-
chloro-2,4-dinitrobenzene working solution (100 μl of
0.060 g reduced glutathione prepared in 10 ml 0.1 M so-
dium phosphate buffer pH 6.5 + 100 μl of 0.013 g 63 mM
1-chloro-2,4-dinitrobenzene, diluted in 1 ml methanol
and 10 ml 0.1 M phosphate buffer at pH 6.5) added to
each replicate of mosquito homogenate. Absorbance was
read at 340 nm every 30 s for 5 min. The rate of forma-
tion of conjugated 1-chloro-2,4-dinitrobenzene was assessed
kinetically from a molecular extinction coefficient
(9.5 mM.cm-1).
Acetylcholinesterase assay
Two 25-μl replicates from each mosquito homogenate
were placed in adjacent wells of a microtitre plate.
Membrane-bound acetylcholinesterase in the mosquito
homogenate was solubilized by adding 145 μl of Triton
phosphate buffer (1% (v/v) Triton X-100 in 0.1 M phos-
phate buffer, pH 7.8). To one set of homogenates, 25 μl
of 0.01 M acetylthiocholine iodide (ASChI) and 10 μl of
0.1 M propoxur solution (2.5 ml 0.1 M ASChI + 10 μl of
0.1 M propoxur in acetone) were added. To the other
replicate, 25 μl of ASChI alone was added. The prepar-
ation was incubated for 3 min at room temperature, and
the kinetics of the enzyme reaction was monitored con-
tinuously at 420 nm for 5 min. The results were
expressed as percentage remaining activity in the inhib-
ited fraction and in the control (uninhibited).
Esterase assays
Non-specific esterase activity was assessed with two sub-
strates, α- and β-naphthol acetate. For both substrates,
90 μl of phosphate buffer saline (pH 6.5) containing 1%
Triton were added to the plate well containing 10 μl of
microfuge supernatant, and the reactions were incubated
at ambient temperature for 10 min, when 100 μl 0.6 M
naphthol was added. After 30 min incubation at ambient
temperature, 100 μl of Fast Garnett BC solution (0.010 g
Fast Garnett salt + 12 ml distilled water) were added to
stop the reaction. The reaction was then incubated for
10 min at room temperature. The concentration of the
final product was determined at 550 nm calculated
from a standard curve of α- or β-naphthol. Esterase-
specific activity per individual was reported as μmol
product.min-1.mg-1 protein.
Biochemical data analysis
Mean absorbance values of replicate wells for each tested
mosquito were converted into enzyme activity and divided
by the protein values. The mean activity of each sample
was calculated and the distributions of enzymatic activities
from wild mosquitoes were compared to those of
reference strain mosquitoes (Ae. aegypti SBE) using
Mann-Whitney tests (nonparametric) with GraphPad
Prism version 5.00 software and Mann-Withney U-test
with MedCalc version 15. Statistical significance was
assumed at P < 0.05. Mann-Whitney test or Kruskal-Wallis
test as appropriated was performed with STATA/IC ver-
sion 11 (StataCorp College Station, Texas 77845) to assess
the association between resistance status and enzymes
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activities in wild specimens but also to the reference strain,
and P-values < 0.05 were considered statistically significant.
Results
Susceptibility to larvicides
Aedes aegypti and Ae. albopictus larvae from all sites
were susceptible to both larvicides, Bti and temephos
(Tables 1 and 2). For Ae. aegypti, the LC50 of Bti was
0.06–0.15 mg/l and the LC95 0.25–0.30 mg/l, with simi-
lar results in Ae. albopictus (LC50, 0.07–0.11 mg/l and
LC95, 0.20–0.27 mg/l). For temephos, the LC50 in Ae.
aegypti was 0.0049–0.0059 mg/l and the LC95 0.0076–
0.0096 mg/l, with values in Ae. albopictus of 0.0042–
0.0057 mg/l and 0.0066–0.01 mg/l, respectively.
Susceptibility to adulticides
The results of WHO tube tests on Ae. aegypti and Ae.
albopictus collected in six districts of Bangui are pre-
sented in Table 3. The mortality rate of negative controls
was < 5%. In Ae. aegypti, resistance to DDT was observed
in four populations, with mortality rates of 71–80%, and
probable resistance in two further populations, with mor-
tality rates of 93 and 94%. Only one population of Ae.
albopictus was susceptible (100% mortality) and the rest
was either suspected to be resistant (95–97% mortality) or
resistant (41–90% mortality). With deltamethrin, Ae.
aegypti from three localities showed mortality rates ≥
98%, while the rates in other populations were between
95 and 97%. Samples of Ae. albopictus collected at two
sites were resistant (rates of 87 and 94%), while all other
populations were sensitive. Bioassays with propoxur and
fenitrothion showed full susceptibility of the populations
of both species, except for one population of Ae. albopic-
tus to propoxur (mortality rate of 94%) and one of Ae.
albopictus to fenitrothion (mortality rate of 96.4%).
Knockdown time
The KDT50 calculated after exposure to DDT ranged
from 35 to 80 min for Ae. aegypti and from 31 to
81.4 min for Ae. albopictus (Table 4). The resistance ra-
tio at KDT50 for DDT was increased for populations of
both species considered as resistant based on their mor-
tality rates. However, these increases were rather limited
and ratios did not exceed 1.6. With deltamethrin, all the
KDT50 values for both species were < 30 min, and the re-
sistance ratio at KDT50 was also increased for some pop-
ulations considered as possibly resistant but ratios were
low and below 2.
Genotyping of kdr mutations
We analysed 80 Ae. aegypti and 93 Ae. albopictus speci-
mens that were survivors of the adult bioassays. None of
the non-synonymous mutations in the voltage-gated
sensitive channel was detected.
Biochemical assays
For each of the four enzyme systems tested, we analysed at
least 25 individuals per species and per population (Figs. 2
and 3). Comparisons with the SBE strain showed significant
differences (Mann-Whitney U-test, P < 0.05) in mean en-
zyme activity in some populations: α-esterase activities were
significantly higher in two Ae. albopictus populations (IPB,
U = 140, Z = 4.84, P < 0.0001, and Sica 1, U = 216, Z = 3.32,
P = 0.0009), and β-esterase activities were significantly
Table 1 Larval bioassays with Bacillus thuringensis israelensis against Aedes aegypti and Ae. albopictus larvae
Strain and site n LC50 (mg/l) (95% CI) LC95 (mg/l) (95% CI) RR50 RR95
Ae. aegypti
IPB 500 0.06 (0.05–0.08) 0.27 (0.22–0.38) 0.85 1.58
Sica 1 500 0.07 (0.04–0.09) 0.25 (0.20–0.35) 1.00 1.47
Lakouanga 500 0.15 (0.12–0.16) 0.30 (0.26–0.42) 1.85 1.57
Ouango 498 0.06 (0.05–0.09) 0.25 (0.20–0.37) 0.85 1.47
Ngongonon 3 500 0.08 (0.06–0.10) 0.27 (0.22–0.36) 1.14 1.58
92 Logements na – –
Ae. albopictus
IPB 500 0.09 (0.06–0.12) 0.21 (0.18–0.23) 1.28 1.23
Sica 1 500 0.08 (0.05–0.10) 0.27 (0.22–0.37) 1.14 1.58
Lakouanga 500 0.11 (0.07–0.16) 0.26 (0.21–0.32) 1.57 1.52
Ouango 500 0.07 (0.05–0.09) 0.23 (0.19–0.30) 1.00 1.35
Ngongonon 3 500 0.10 (0.07–0.11) 0.2 (0.20–0.27) 1.42 1.17
92 Logements na – –
Reference strain 500 0.07 (0.05–0.08) 0.17 (0.15–0.21)
Abbreviations: na not available; LC50 and LC95, 50 and 95% lethal concentrations; CI Confidence interval, RR Resistance ratio
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higher in all five populations of Ae. aegypti (IPB,U = 429.5,
Z = 1.98, P = 0.04; Sica 1, U = 284, Z = 2.3, P = 0.02;
Lakouanga, U = 258, Z = 2.69, P = 0.007; Ouango, U =
214.5, Z = 3.34, P = 0.0008; and Ngongonon 3, U = 230.5,
Z = 3.1, P = 0.001) and three Ae. albopictus populations
(IPB, U = 118, Z = 5.14, P < 0.0001; Sica 1, U = 84, Z =
5.3, P < 0.0001; and Lakouanga, U = 168, Z = 4.04, P =
0.0001.
Significantly higher MFO activity was observed in
three Ae. aegypti populations (IPB, U = 404, Z = 2.29,
P = 0.02; Ouango, U = 296, Z = 2.12, P = 0.03; and Ngongo-
non 3, U = 296.5, Z = 2.11, P = 0.03) and two Ae.
Table 2 Larval bioassays with temephos against Aedes aegypti and Ae. albopictus larvae
Strain and site n LC50 (mg/l) (95% CI) LC95 (mg/l) (95% CI) RR50 RR95
Ae. aegypti
IPB 800 0.0055 (0.0047–0.0060) 0.0089 (0.0084–0.0098) 1.17 1.21
Sica 1 800 0.0059 (0.0052–0.0064) 0.0096 (0.0089–0.0108) 1.25 1.31
Lakouanga 800 0.0054 (0.0043–0.0063) 0.0076 (0.0068–0.0082) 1.14 1.04
Ouango 790 0.0052 (0.0046–0.0061) 0.0082 (0.0076–0.0091) 1.10 1.12
Ngongonon 3 788 0.0049 (0.0035–0.0057) 0.0079 (0.0073–0.0085) 1.08 1.08
92 Logements 782 0.0057 (0.0038–0.0061) 00095 (0.0080–0.0093) 1.21 1.30
Ae. albopictus
IPB 800 0.0050 (0.0014–0.0063) 0.0091 (0.0083–0.0148) 1.06 1.24
Sica 1 800 0.0050 (0.0012–0.0068) 0.01 (0.078–0.0127) 1.06 1.36
Lakouanga 797 0.0055 (0.0047–0063) 0.0082 (0.0077–0.0133) 1.17 1.12
Ouango 769 0.0048 (0.0037–0.0058) 0.0078 (0.0067–0.0084) 1.02 1.06
Ngongonon 3 800 0.0057 (0.0046–0.0063) 0.0098 (0.0091–0.011) 1.21 1.34
92 Logements 788 0.0042 (0.0034–0.0054) 0.0066 (0.0055–0.0078) 0.89 0.90
Reference strain 800 0.0047 (0.0020–0.0108) 0.0073 (0.0055–0.0097)
Abbreviations: LC50 and LC95, 50 and 95% lethal concentrations; CI Confidence interval, RR Resistance ratio
Table 3 Mortality rates of adult Aedes aegypti and Ae. albopictus from Bangui and neighbourhoods 24 h after exposure to
insecticides
Species and site % mortality (no. of mosquitoes assayed)
Organochlorine Pyrethroid Carbamate Organophosphate
4% DDT Status 0.05% deltamethrin Status 0.1% propoxur Status 0.5% fenitrothion Status
Ae. aegypti
IPB 71.5 (88) R 95.4 (88) RS 99 (100) S 100 (88) S
Sica 1 78 (100) R 95.6 (93) RS 100 (100) S 100 (100) S
Lakouanga 79.5 (93) R 98 (100) S 100 (100) S 100 (100) S
Ouango 93.4 (92) RS 100 (50) S 98 (50) S 100 (100) S
Ngongonon 3 94 (100) RS 97 (100) RS 100 (99) S 100 (88) S
92 Logements 78 (50) R 100 (100) S 100 (50) S na –
Ae. albopictus
IPB 96.2 (79) RS 100 (100) S 100 (75) S 100 (89) S
Sica 1 80.2 (96) R 87 (100) RS 99 (98) S 100 (93) S
Lakouanga 95.7 (71) RS 99 (89) S 100 (94) S 100 (100) S
Ouango 90 (97) R 99 (97) S 100 (100) S 100 (100) S
Ngongonon 3 100 (80) S 100 (93) S 100 (84) S 96.4 (84) RS
92 Logements 41 (100) R 94 (100) RS 94 (50) RS 100 (100) S
Reference strain 100 (100) 100 (100) 100 (100) 100 (100)
Abbreviations: na Not available, R Resistant, RS Suspected resistance, S Susceptible
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albopictus populations (IPB, U = 66, Z = 5.86, P < 0.0001
and Sica 1, U = 264, Z = 2.6, P = 0.009). The mean rate of
inhibition of AChE activity in the presence of propoxur
was significantly lower in two Ae. aegypti populations
(Lakouanga, U = 191, Z = 3.69, P = 0.0002 and Ouango, U
= 206, Z = 3.47, P = 0.0005) and in two Ae. albopictus pop-
ulations (Lakouanga, U = 205, Z = 3.48, P = 0.0005 and 92
Logements, U = 92, Z = 5.18, P < 0.0001), suggesting that
they contained some individuals with reduced sensitivity.
Glutathione S-transferase activity was significantly higher
than control in two populations of Ae. aegypti (Ouango,
U = 155.5, Z = 4.22, P < 0.0001 and Ngongonon 3,U = 295,
Z = 2.13, P = 0.03) and in three populations of Ae. albo-
pictus (IPB, U = 223, Z = 3.69, P = 0.0002, Sica 1, U =
287, Z = 2.25, P = 0.024 and 92 Logements, U = 156.5,
Z = 4.24, P < 0.0001). Statistical analysis performed to
assess association between enzyme activities and re-
sistance status of Aedes spp. populations. This showed
that resistance status is significantly associated to cer-
tain enzyme activities such as GST and CytP450 in Ae.
aegypti (Additional file 1: Table S1), and EST (α- and
β-), GST and CytP450 in Ae. albopictus (Additional file
1: Table S2). This showed also that enzyme activities of
field strain in both Aedes spp. is generally high than those
of susceptible laboratory strains.
Discussion
The results of the larval bioassays with Bti and temephos
indicated satisfactory susceptibility in all samples of Ae.
aegypti and Ae. albopictus assayed. Full resistance to Bti
has not been reported in field populations of either
Aedes species although it was found in Culex pipiens
in New York State [51]. This larvicide acts as a mix-
ture of toxins with different modes of action, which
reduces resistance in targeted populations. As Bti is
highly specific to some Diptera and might be consid-
ered a biological control agent, it is the first choice of
larvicide for use against Aedes species [39, 52]. For
temephos, our results suggest full susceptibility of all
the tested populations. Nevertheless, resistance to this
compound has been reported in Ae. aegypti in Brazil
[53] and Santiago Island in Cape Verde [54] and in Ae.
albopictus in Greece [55]. Insecticide resistance results
from extensive, long-term use [20, 21]; thus, for example,
in Brazil, resistance to temephos compromises its use by
the national dengue control programme [56, 57]. Although
this insecticide was used moderately in Central Africa
(Cameroon and Gabon) in the 1970s [38], it had never
been used in vector control programmes in CAR, which
probably explains the full susceptibility we observed for
both species.
None of the Ae. aegypti populations from Bangui can
be considered fully susceptible to DDT, as all were either
possibly resistant or resistant. The same was true for Ae.
albopictus, although the mortality rates were sometimes
lower (41%). Mouchet et al. [38] previously reported
decreased susceptibility to DDT in Ae. aegypti sampled
in Bangui in 1965 and 1971, suggesting continuing
Table 4 Knockdown times in minutes of Aedes aegypti and Ae. albopictus exposed to 4% DDT and 0.05% deltamethrin. Estimates are
from probit analyses with 95% confidence intervals (CI). Resistance ratios (RRs) are calculated as the ratio of the KDT50 of the field
population to that of the control population
Insecticide Site Ae. aegypti Ae. albopictus
KDT50 (95% CI) KDT95 (95% CI) KDT50 ratio (RR) KDT50 (95% CI) KDT95 (95% I CI) KDT50 ratio (RR)
4% DDT
IPB 63 (57.6–71.9) 115.6 (100.7–139.2) 1.2 46.5 (43.2–50.7) 91.4 (82.1–104.8) 1
Sica 1 55.5 (53.4–58.1) 85.2 (80.0–92.1) 1.1 81.4 (70.0–103.5) 133.0 (109.1–180.7) 1.6
Lakouanga 61.2 (57.9–65.5) 98.0 (90.1–108.8) 1.2 48.0 (46.1–50.3) 71.4 (67.0–77.3) 1
Ouango 34.6 (32.6–36.5) 61.1 (57.4–65.7) 0.7 76.6 (65.1–98.0) 172.0 (138.0–237.5) 1.5
Ngongonon 3 40.4 (39.3–41.6) 60.1 (57.9–62.6) 0.8 30.5 (27.8–33.3) 57.4 (52.2–64.8) 0.6
92 Logements 79.8 (69.9–98.5) 127.6 (106.3–169.5) 1.6 65.5 (60.6–78.8) 80.7 (71.1–108.1) 1.3
Reference strain 50.2 (47.3–52.2) 90.4 (85.3–94.) 1 – –
0.05% deltamethrin
IPB 14.8(11.9–15.2) 23.5 (21.3–25.8) 1.1 15.8 (8.1–21.5) 27.8 (21.9–48.7) 1.2
Sica 1 21.2 (14.9–26.3) 40 (34.2–54.5) 1.6 26.8 (18.2–33.6) 54.9 (45.4–77.2) 2
Lakouanga 12.1 (10.7–14.7) 27.4 (24.8–29.7) 1 14.3 (11.8–16.1) 23.5 (18–38.1) 1.1
Ouango 23.1(20.3–25.7) 42.01 (38.0–47.7) 1.7 10.1 (4.4–13.6) 24.0 (19.5–34.3) 0.8
Ngongonon 3 14.1 (12.1–15.9) 26.3 (23.6–0.4) 1.1 13.9 (12.5–15.2) 28.1 (26.0–31.0) 1
92 Logements 18.6 (17.8–19.5) 29.3 (27.9–30.9) 1.4 23.6 (13.8–30.9) 45.0 (36.4–67.7) 1.8
Reference strain 13.4 (10.2–14.6) 24.8 (22.3–24.1) 1 – –
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selection pressure on Aedes populations. DDT resistance
has repeatedly been reported in Ae. aegypti [24, 58] and
Ae. albopictus [59, 60], although data for the latter are
scarce. The decreased susceptibility to deltamethrin ob-
served in both populations may represent an obstacle
for vector control programmes, because pyrethroids are
recommended for the control of adult Aedes mosqui-
toes [61, 62].
The resistance to DDT and deltamethrin observed in
both species is difficult to explain, because in CAR, as in
other countries of Central Africa, use of insecticides
against Ae. aegypti and Ae. albopictus is limited [39].
CAR has promoted use of long-lasting insecticidal nets
as one of the main components of the national malaria
control programme, with indoor residual spraying by
households with insecticides available on the market,
which we noted at nearly every study site. Therefore,
insecticides used against other insects of medical or
agricultural importance may exert indirect selection
pressure on these two mosquito species [63, 64]. Similar
observations have been made for resistance of Ae. aegypti
to deltamethrin in Indonesia [65], Thailand [61] and
Nigeria [58]. As Ae. albopictus was reported for the first
time in CAR in 2009 [66], we cannot exclude the possi-
bility of invading populations with resistance to DDT,
as suggested by Kamgang et al. [39] in Cameroon.
In this study, the kdr mutations I1011M/V, V1016G/I,
F1534C in Ae. aegypti and F1534C in Ae. albopictus were
not detected in mosquitoes that survived to DDT or delta-
methrin, in accordance with the finding that knockdown
Fig. 2 Activity profiles of non-specific α- and β-esterases and mixed-function oxidases (cytochrome P450) in Ae. aegypti (a, c, e) and Ae. albopictus
(b, d, f). Numbers in parentheses indicate the number of mosquitoes assayed. Asterisks indicate significant increase in wild populations compared
to SBE susceptible strain values (P < 0.05, Mann-Whitney tests). Abbreviations: SBE, Benin strain; IPB, Institut Pasteur de Bangui; NES, non-specific
esterase; MFO, mixed-function oxidase
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time was not or weakly increased during insecticide ex-
posure in test tubes. We observed increased activity of
several enzymes in Ae. aegypti and Ae. albopictus samples
that might explain the decreased susceptibility to DDT
and pyrethroids. Although the mean activity of β-esterase
was increased significantly in some populations of Ae.
aegypti and Ae. albopictus, there was no evidence of resist-
ance to deltamethrin in these samples according to WHO
diagnostic concentrations [42]; however, most of the
WHO diagnostic concentrations were established for
Anopheles species, and it is possible that they are not
transposable to Aedes or Culex mosquitoes. The diag-
nostic concentrations on these species for the main in-
secticides used in control vector should therefore be
assessed. Although elevated esterase and glutathione
S-transferase activities can be involved in temephos re-
sistance [67], in our study all the populations were
fully susceptible to this insecticide.
High MFO activity was found in three Ae. aegypti and
three Ae. albopictus populations, but also with no clear
association with full resistance to deltamethrin. In
contrast, Paeporn et al. [68] in Thailand showed that
increased MFO and esterase activities in Ae. aegypti
strains were associated with pyrethroid (deltamethrin
and permethrin) resistance, and Saavedra-Rodriguez et
al. [69] reported that mixed-function oxidases and es-
terases were important in resistance to organophos-
phate insecticides in Ae. aegypti populations in Latin
America. Reduced activity of AChE to propoxur inhib-
ition was detected in some individuals of Ae. aegypti
and Ae. albopictus, suggesting possible emergence of
resistance to carbamates or other organophosphates in
field populations.
Conclusion
We describe for the first time the susceptibility of Aedes
in CAR to the main insecticide classes and the mecha-
nisms potentially involved in resistance. This informa-
tion adds to that on the susceptibility of Ae. aegypti and
Ae. albopictus to commonly used insecticides in Central
Africa. The susceptibility of both species to Bti and teme-
phos is encouraging for larval control in Bangui; however,
most Ae. aegypti and Ae. albopictus samples were resistant
or suspected of being resistant to DDT. Moreover, some
Fig. 3 Profiles of acetylcholinesterase inhibition and glutathione S-transferase in Ae. aegypti (a, c) and Ae. albopictus (b, d). Numbers in parentheses
indicate the number of mosquitoes assayed. Asterisks indicate significant differences compared to SBE susceptible strain values (P< 0.05, Mann-Whitney
tests). Abbreviations: SBE, Benin strain; IPB, Institut Pasteur de Bangui; AChE, acetylcholinesterase; GST, glutathione S-transferase
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populations of both species showed possible resistance to
deltamethrin according to the WHO criteria. The absence
of kdr mutations in the two species cannot explain the de-
creased sensitivity; however, differences in the activity of
certain enzymes involved in metabolism could explain
differences in susceptibility between populations. The
results with propoxur (carbamate) and fenitrothion
(organophosphate) were satisfactory, as decreased sensi-
tivity was found in only one population of Ae. albopictus
for propoxur and one for fenitrothion. These findings are
important for effective control of DENV, CHIKV and
ZIKV vectors in CAR. Further studies with the Centers for
Disease Control and Prevention bottle bioassay and syner-
gists should be conducted to obtain additional informa-
tion on metabolic-mediated resistance mechanisms.
Additional files
Additional file 1: Table S1. Assessing association between resistance
status and enzyme activities in Ae. aegypti. Table S2. Assessing association
between resistance status and enzyme activities in Ae. abopictus. (DOC 135 kb)
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